Advertisement

Topics

Companies Related to "Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer" [Most Relevant Company Matches] RSS

13:12 EDT 25th September 2018 | BioPortfolio

Here are the most relevant search results for "Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Epothilone Second Line Treatment Patients With Advanced Metastatic" Companies 1–25 of 8,500+

Relevant

SolaranRx, Inc.

SolaranRx, Inc. is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for treating metastatic melanoma. SolaranRx seeks to improve treatment and patientsâ€...


SolaranRx

SolaranRx, Inc. is developing a platform of new therapies and companion imaging agents for the treatment of metastatic melanoma. This merger between therapeutics and diagnostics—often referred to as theranostics—constitutes a new level of personalized medicine for treating advanced melanoma. SolaranRx seeks to improve treatment and patients’...

A&G Pharmaceutical Incorporated

A&G Pharmaceutical, Inc. (A&G) was incorporated in Delaware on June 6, 2000, as a "C" Corporation, to make use of two proprietary technologies that are unique to the Company. A&G is located in Baltimore, Maryland, and consists of two distinct but integrate divisions: 1) the Pharmaceutical Division and 2) the Monoclonal Antibody Services Division. Pharmaceutical Division Breast cancer is the most ...


Cytogen

Cytogen is a specialty pharmaceutical company dedicated to advancing the treatment and care of cancer patients by building, developing, and commercializing a portfolio of oncology products. The Company's specialized sales force currently markets QUADRAMET® (samarium Sm-153 lexidronam injection), PROSTASCINT® (capromab pendetide), and SOLTAMOX™ (tamoxifen citrate) to the U.S. oncology market. Q...

WILEX AG

WILEX is a biopharmaceutical company developing novel cancer therapies for the treatment of various tumors including renal and breast cancer. Therapies are based upon biologic targets directly connected to cancer progression and pathogenesis in order to provide effective and well-tolerated treatment and enhance patients' quality of life.The company has a portfolio of cancer drug candidates ranging...

Glactone Pharma AB

Glactone Pharma AB is developing a drug for the treatment of castration resistant prostate cancer. Research has shown that the natural product galiellalactone can modulate a signaling protein (STAT3) that is over activated in cancer cells. The goal is to develop drugs against metastasizing cancer where galiellalactone is used as a chemical starting point to make new novel, patentable compounds. ...

Advanced Neuromodulation Systems

Welcome to Advanced Neuromodulation Systems Successful treatment of a chronic pain or neurological condition begins with expanding your knowledge and exploring your options.Welcome to Advanced Neuromodulation Systems where our neurostimulation and drug pump technologies are advancing treatment standards for chronic pain and neurological disorders, broadening treatment choices for patients and phys...

Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those ...

The Center for Advanced Medicine and Clinical Research

Since 1996, The Center for Advanced Medicine & Clinical Research has helped people with "untreatable conditions" and those who cannot be cured by traditional medicine. Under the direction of Dr. Rashid A. Buttar, the Center implements a holistic approach, incorporating mainstream medicine as well as various disciplines and treatments with advanced medical concepts and techniques to help patients r...

Cancer Treatment Centers of America, Inc.

Cancer Treatment Centers of America, Inc. (CTCA) is a national network of hospitals focusing on complex and advanced stage cancer. CTCA offers a comprehensive, fully integrated approach to cancer treatment and serves patients from all 50 states at facilities located in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Stand...

amcure GmbH

amcure GmbH is a spin-off from the Karlsruhe Institute of Technology established in 2011. The company develops peptide-based compounds for the treatment of highly metastatic forms of cancer. amcure’s most advanced development candidate has entered preclinical development. In vivo proof-of-concept studies indicate high efficacy against different types ...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Advanced Cardiac Therapeutics, Inc.

Headquartered in Laguna Beach, Calif., privately held Advanced Cardiac Therapeutics, Inc. specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology for the treatment of patients with cardiac arrhythmias. For more information visit www.actmed.net.

Arkansas Heart Hospital

Arkansas Heart Hospital is dedicated to the diagnosis and treatment of heart disease. By specializing in the nation's number one killer, patients at Arkansas Heart Hospital experience the benefits of advanced technology while receiving services that focus on their individual needs. The concept of a facility dedicated to diagnosing and treating patients with cardiovascular disease allows staff and ...

Next Advanced Medicine

An interdisciplinary medical practice in Irvine, Calif., Next Advanced Medicine, under the direction of Candice Hall, D.C., focuses on the treatment and reversal of chronic diseases such as diabetes, and autoimmunity such as thyroid disease. Unlike traditional medical professionals, the staff at Next Advanced Medicine provide an alternative approach for pa...

Lion Biotechnologies, Inc.

Lion Biotechnologies, Inc., formerly Genesis Biopharma, Inc., is engaged in the development of T-cells and engineered T-cells for the treatment of various cancers. The company's lead product candidate is a ready-to-infuse autologous T-cell therapy utilizing tumor-infiltrating lymphocytes (TILs) for the treatment of patients with Stage IV metastatic melanom...

EnzySurge Ltd

EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds. EnzySurge's DermaStream(R) platform offers a new and unique wound treatment modality by continuously streaming a fresh supply of advanced therapeutic solutions to a controlled wound environment. DermaStream is designed to deliver effective, affordable and easy-to-use wound tre...

Cancer Treatment Centers of America

Cancer Treatment Centers of America®, Inc. (CTCA) is a national network of hospitals providing a comprehensive, fully integrated approach to cancer treatment. CTCA serves patients with advanced cancer from all 50 states at facilities located in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. Known for delivering the Mother Standard® of care ...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

OncoGenex Technologies Inc.

OncoGenex Technologies Inc. (OncoGenex) is a clinical-stage biotechnology company dedicated to improving survival and quality of life of cancer patients by developing targeted therapeutics for treatment-resistant and metastatic cancer. The company's lead drug candidate, OGX-011, has commenced Phase 2 studies in prostate cancer (2), NSCLC and breast cancer. OGX-427 is in preclinical development and...

Tennessee Cancer Patient Coalition

The Tennessee Cancer Patient Coalition’s mission is to serve as an advocate for cancer patients and their caregivers. The Coalition believes cancer patients should have the opportunity to make informed decisions about their care and have equal access to the most advanced treatment methods available. Proton Therapy is the most advanced form of radiatio...

Delcath Systems, Inc.

Delcath Systems, Inc. is a development stage, specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of pri...

Panagin Pharmaceuticals Inc.

Panagin Pharmaceuticals Inc., a privately-held biotech company, specializes in the discovery, research, development and commercialization of saponin based anti-cancer drugs. Panagin's proprietary new drug candidates show strong anti-cancer properties against various advanced, metastatic, multi-drug resistant cancers. Panagin's research and clinical programs focus on life-threatening diseases, such...

Cancer Treatment Centers of America at Eastern Regional Medical Center

Cancer Treatment Centers of America (CTCA) is a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment. CTCA serves patients with advanced cancer from all 50 states at facilities located in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. For more information about Cancer Treatment Centers of America, go to cancercenter.com.

US Bioscience Incorporated

US Bioscience, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for patients with cancer and allied diseases such as AIDS. Currently, three of the Company's products are marketed by US Bioscience and its commercial partners: Ethyol® (amifostine) A selective cytoprotective agent for reduction of toxicities associated with cancer chemotherapy. Hexalen...


More From BioPortfolio on "Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks